Carbidopa-levodopa remains the most effective medication for many Parkinson’s disease movement symptoms, but neurologists have several additional treatment options when symptoms fluctuate or medication alone is not enough. Depending on the individual, doctors may consider MAO-B inhibitors, COMT inhibitors, dopamine agonists, amantadine, inhaled levodopa, or other therapies.
Several medications can be used alongside levodopa or, in selected circumstances, as alternatives.
Common options include:
These medicines have different benefits and risks, so treatment needs to be individualized.
Some people eventually experience motor fluctuations, where Parkinson’s symptoms return before the next medication dose takes effect. Others may develop dyskinesia, which involves involuntary movements.
Doctors may respond by:
The goal is to provide more consistent symptom control while limiting troublesome side effects.
For some people with Parkinson’s whose symptoms remain difficult to control despite medication adjustments, neurologists may discuss advanced therapies.
Deep brain stimulation (DBS) involves implanting electrodes that deliver electrical stimulation to specific areas of the brain involved in movement. It can reduce tremor, stiffness, slowness, dyskinesia, and medication-related fluctuations in appropriately selected patients.
DBS is not a cure and does not treat every Parkinson’s symptom. A specialist evaluation is needed to determine whether someone is a suitable candidate.
Continuous medication delivery can provide another approach for people experiencing significant motor fluctuations. The Parkinson’s Foundation lists pump-based treatments among advanced options used when oral medications are no longer providing adequate control.
Treatment extends beyond medication and procedures. Physical, occupational, and speech therapy can help address issues involving walking, balance, movement, speech, and daily activities. Exercise can also support strength, flexibility, balance, and coordination.
Depending on individual needs, a care plan may include:
Focused ultrasound and other lesion-based procedures may be considered for selected patients, particularly for medication-resistant tremor. These procedures target specific brain regions without implanting a stimulation device. However, they are less commonly used than DBS and other established advanced treatments.
There is no single treatment combination that works for everyone with Parkinson’s disease. Doctors may consider:
Medication choices should also account for potential interactions with other medicines and supplements.
Parkinson’s treatment in 2026 goes beyond simply taking carbidopa-levodopa tablets. Depending on individual circumstances, neurologists may use additional medications, on-demand therapies, continuous medication delivery, DBS, focused ultrasound, and rehabilitation strategies to improve symptom control and quality of life. Carbidopa-levodopa remains an important treatment, and alternatives are generally considered to complement it or address specific problems rather than replace it for everyone.